20. New Treatment Modalities: 108 DOSE ADJUSTED EPOCH RITUXIMAB: A NOVEL PHARMACODYNAMIC REGIMEN WITH HIGH EFFICACY IN ALL CLINICAL RISK GROUPS, AND GCB AND ABC SUBTYPES OF …
Annals of Occupational Hygiene（2005）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要